SN BioScience initiates patient dosing in phase 1b/2 clinical trial of SNB-101 to treat extensive-stage small cell lung cancer: Seongnam, South Korea Saturday, May 16, 2026, 17:00 ...

Results from the MagnetisMM-5 study showed that Elrexfio significantly improved progression-free survival, which means patients lived longer without their cancer growing or spreading, compared with ...

GLP-1 type medications help control appetite and lose weight – and there are 8 habits that will prevent you from enjoying ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

The long scientific journey that led to the drug for pancreatic cancer is a triumph of both public and private research ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

One minute your pet's fine, the next something's off and you just know it. Maybe it’s the way they’re acting, or something ...

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its global Phase 1b/2 clinical trial evaluating ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with ...

Patients with one of the deadliest cancers have been pleading for this yet-unapproved treatment that may prolong their lives.

OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly ...